{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:17:33Z","timestamp":1790756253921,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T00:00:00Z","timestamp":1479772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.survophthal.2016.11.008","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T20:15:49Z","timestamp":1480018549000},"page":"286-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Drug-induced corneal epithelial changes"],"prefix":"10.1016","volume":"62","author":[{"given":"Michael B.","family":"Raizman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Hamrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis S.","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Rapuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger G.","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2016.11.008_bib1","first-page":"399","article-title":"Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics","volume":"7","author":"Agarwal","year":"2014","journal-title":"Pharmgenomics Pers Med"},{"issue":"5","key":"10.1016\/j.survophthal.2016.11.008_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3341\/kjo.2011.25.5.355","article-title":"Vortex keratopathy in a patient receiving vandetanib for non-small cell lung cancer","volume":"25","author":"Ahn","year":"2011","journal-title":"Korean J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2016.11.008_bib3","first-page":"872","article-title":"The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population","volume":"56","author":"Alexander","year":"1985","journal-title":"J\u00a0Am Optom Assoc"},{"issue":"23","key":"10.1016\/j.survophthal.2016.11.008_bib4","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4103\/0301-4738.82012","article-title":"Crystalline deposition in the cornea and conjunctiva secondary to long-term clofazimine therapy in a leprosy patient","volume":"59","author":"Barot","year":"2011","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.11.008_bib6","first-page":"553","article-title":"Some iatrogenic ocular diseases from systemically administered drugs","volume":"10","author":"Bernstein","year":"1970","journal-title":"Int Ophthalmol Clin"},{"issue":"3 Pt 1","key":"10.1016\/j.survophthal.2016.11.008_bib7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0002-9394(79)90633-0","article-title":"Epithelial deposition of gold in the cornea in patients receiving systemic therapy","volume":"88","author":"Bron","year":"1979","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.11.008_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4269\/ajtmh.1951.s1-31.617","article-title":"Experimental therapy of onchocerciasis with suramin and hetrazan; results of a three-year study","volume":"31","author":"Burch","year":"1951","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.survophthal.2016.11.008_bib9","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/JTO.0000000000000634","article-title":"Vortex keratopathy presumed secondary to AZD9291","volume":"10","author":"Chia","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.11.008_bib10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00003226-199709000-00019","article-title":"Vortex keratopathy in a patient with multiple myeloma","volume":"16","author":"Chong","year":"1997","journal-title":"Cornea"},{"issue":"1\u20132","key":"10.1016\/j.survophthal.2016.11.008_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00139581","article-title":"Drug-induced lipidoses of the cornea and conjunctiva","volume":"4","author":"D'Amico","year":"1981","journal-title":"Int Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.11.008_bib12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archopht.1981.03930010259007","article-title":"Amiodarone keratopathy: drug-induced lipid storage disease","volume":"99","author":"D'Amico","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.11.008_bib13","series-title":"Ophthalmology - Current Clinical and Research Updates","first-page":"385","article-title":"Fabry disease\u2014ocular manifestations and visual symptoms","author":"Davey","year":"2014"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jac\/34.4.605","article-title":"Toxicity of clarithromycin in the treatment of Mycobacterium avium complex infection in a patient with AIDS","volume":"34","author":"Dorrell","year":"1994","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.survophthal.2016.11.008_bib15","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00417-006-0365-8","article-title":"In\u00a0vivo confocal microscopy in hydroxychloroquine-induced keratopathy","volume":"245","author":"Dosso","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"Pt 4","key":"10.1016\/j.survophthal.2016.11.008_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/eye.1996.98","article-title":"Vortex or whorl formation of cultured human corneal epithelial cells induced by magnetic fields","volume":"10","author":"Dua","year":"1996","journal-title":"Eye (Lond)"},{"issue":"Pt 1","key":"10.1016\/j.survophthal.2016.11.008_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/eye.1993.12","article-title":"Corneal epithelial cell migration in humans: \u2018hurricane and blizzard keratopathy\u2019","volume":"7","author":"Dua","year":"1993","journal-title":"Eye (Lond)"},{"issue":"10","key":"10.1016\/j.survophthal.2016.11.008_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/jop.2015.0064","article-title":"Ocular adverse\u00a0events associated with antibody-drug conjugates in human clinical trials","volume":"31","author":"Eaton","year":"2015","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.survophthal.2016.11.008_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","article-title":"Fabry disease: guidelines for the evaluation and management of multi-organ system involvement","volume":"8","author":"Eng","year":"2006","journal-title":"Genet Med"},{"issue":"Pt 1","key":"10.1016\/j.survophthal.2016.11.008_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/eye.1996.30","article-title":"Vortex keratopathy associated with ibuprofen therapy","volume":"10","author":"Fitt","year":"1996","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2016.11.008_bib21","series-title":"Physicochemical Principles of Pharmacy in Manufacture, Formulation and Clinical Use","year":"2015"},{"issue":"10","key":"10.1016\/j.survophthal.2016.11.008_bib22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/01.ico.0000240084.27663.fd","article-title":"Corneal toxicity from topical ocular and systemic medications","volume":"25","author":"Fraunfelder","year":"2006","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib23","first-page":"178","article-title":"Amiodarone-induced ultrastructural changes in human eyes","volume":"19","author":"Ghosh","year":"1984","journal-title":"Can J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2016.11.008_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/bjo.68.8.553","article-title":"Severe ocular side effects of perhexilene maleate: case report","volume":"68","author":"Gibson","year":"1984","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2016.11.008_bib25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1517\/17425255.2012.708337","article-title":"Ocular toxicity from systemically administered xenobiotics","volume":"8","author":"Gokulgandhi","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"10.1016\/j.survophthal.2016.11.008_bib26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bjo.72.6.434","article-title":"Indomethacin retinopathy: case report and review","volume":"72","author":"Graham","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.11.008_bib27","first-page":"663","article-title":"Skin pigmentation and corneal and lens opacities with prolonged chlorpromazine therapy","volume":"90","author":"Greiner","year":"1964","journal-title":"Can Med Assoc J"},{"issue":"5","key":"10.1016\/j.survophthal.2016.11.008_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000298751","article-title":"Cytosine-arabinoside-induced keratopathy: a model of corneal proliferation kinetics","volume":"224","author":"Guthoff","year":"2010","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.survophthal.2016.11.008_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol Pathol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.11.008_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/archopht.1983.01040010066010","article-title":"Corneal and conjunctival effects of monobenzone in patients with vitiligo","volume":"101","author":"Hedges","year":"1983","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.11.008_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0002-9394(14)70277-6","article-title":"Ocular symptoms and signs associated with suramin sodium treatment for metastatic cancer of the prostate","volume":"121","author":"Hemady","year":"1996","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.11.008_bib32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0002-9394(88)90838-0","article-title":"Suramin keratopathy","volume":"106","author":"Holland","year":"1988","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2016.11.008_bib33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.icu.0000143688.45232.15","article-title":"Drug-induced corneal complications","volume":"15","author":"Hollander","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.11.008_bib34","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1073\/pnas.79.5.1663","article-title":"Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity","volume":"79","author":"Hostetler","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.survophthal.2016.11.008_bib35","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.clinthera.2008.10.021","article-title":"Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review","volume":"30","author":"Iaccheri","year":"2008","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.survophthal.2016.11.008_bib36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/bjo.66.10.676","article-title":"Ocular changes resulting from therapy with amiodarone","volume":"66","author":"Ingram","year":"1982","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2016.11.008_bib37","first-page":"1477","article-title":"The clinical spectrum of amiodarone-associated optic neuropathy","volume":"96","author":"Johnson","year":"2004","journal-title":"J\u00a0Natl Med Assoc"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jps.20792","article-title":"Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications","volume":"96","author":"Kaufmann","year":"2007","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.survophthal.2016.11.008_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1172-4-7","article-title":"Corneal dystrophies","volume":"4","author":"Klintworth","year":"2009","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.survophthal.2016.11.008_bib40","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/bjo.73.8.669","article-title":"Corneal subepithelial monoclonal kappa IgG deposits in essential cryoglobulinaemia","volume":"73","author":"Kremer","year":"1989","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib41","first-page":"173","article-title":"Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes","volume":"18","author":"Lal","year":"1993","journal-title":"J\u00a0Psychiatry Neurosci"},{"issue":"Pt 4","key":"10.1016\/j.survophthal.2016.11.008_bib42","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/eye.1989.65","article-title":"Corneal epithelial cell movement in humans","volume":"3","author":"Lemp","year":"1989","journal-title":"Eye (Lond)"},{"issue":"12","key":"10.1016\/j.survophthal.2016.11.008_bib43","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1001\/archopht.117.12.1662","article-title":"Chlorpromazine-induced refractile corneal deposits and cataract","volume":"117","author":"Leung","year":"1999","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.11.008_bib44","first-page":"307","article-title":"Characteristics of ocular abnormalities in gout patients","volume":"6","author":"Lin","year":"2013","journal-title":"Int J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0002-9394(00)00494-3","article-title":"Lisch corneal dystrophy is genetically distinct from Meesmann corneal dystrophy and maps to xp22.3","volume":"130","author":"Lisch","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.11.008_bib46","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.eye.6700451","article-title":"Cytarabine-induced corneal toxicity","volume":"17","author":"Lochhead","year":"2003","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.survophthal.2016.11.008_bib47","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00003226-200308000-00017","article-title":"Confocal microscopy in ocular chrysiasis","volume":"22","author":"L\u00f3pez","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2016.11.008_bib48","first-page":"2","article-title":"Predicting the mechanism of phospholipidosis","volume":"4","author":"Lowe","year":"2012","journal-title":"J\u00a0Cheminform"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib49","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0039-6257(97)00118-5","article-title":"Ocular side effects of amiodarone","volume":"42","author":"M\u00e4ntyj\u00e4rvi","year":"1998","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2016.11.008_bib50","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"American Academy of Ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2016.11.008_bib51","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcjo.2013.03.018","article-title":"Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity","volume":"48","author":"Mart\u00ednez-Costa","year":"2013","journal-title":"Can J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2016.11.008_bib52","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.ophtha.2015.05.029","article-title":"Paraproteinemic keratopathy: the expanding diversity of clinical and pathologic manifestations","volume":"122","author":"Milman","year":"2015","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2016.11.008_bib53","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.wno.0000177290.09649.38","article-title":"Amiodarone and optic neuropathy: the heart of the matter","volume":"25","author":"Murphy","year":"2005","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.11.008_bib54","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/AAC.00354-09","article-title":"Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects","volume":"54","author":"Nasveld","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.survophthal.2016.11.008_bib55","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1200\/JCO.1996.14.3.1018","article-title":"Tamoxifen-associated eye disease. A review","volume":"14","author":"Nayfield","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.survophthal.2016.11.008_bib56","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/bjo.87.7.902","article-title":"Detecting chloroquine retinopathy: electro-oculogram versus colour vision","volume":"87","author":"Neubauer","year":"2003","journal-title":"Br J Ophthalmol"},{"issue":"Pt 6","key":"10.1016\/j.survophthal.2016.11.008_bib57","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/eye.1999.217","article-title":"Ocular toxicity in low-dose tamoxifen: a prospective study","volume":"13","author":"Noureddin","year":"1999","journal-title":"Eye (Lond)"},{"issue":"10","key":"10.1016\/j.survophthal.2016.11.008_bib58","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0161-6420(84)34165-3","article-title":"Clinical experience and grading of amiodarone keratopathy","volume":"91","author":"Orlando","year":"1984","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2016.11.008_bib59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1076\/opge.24.3.129.15609","article-title":"Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients","volume":"24","author":"Orssaud","year":"2003","journal-title":"Ophthalmic Genet"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib60","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/112067211002000421","article-title":"Corneal chrysiasis: in\u00a0vivo confocal microscopy analysis","volume":"20","author":"Paladini","year":"2010","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.11.008_bib61","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.amjmed.2011.09.020","article-title":"Amiodarone-associated optic neuropathy: a critical review","volume":"125","author":"Passman","year":"2012","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.survophthal.2016.11.008_bib62","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(19920615)69:12<2961::AID-CNCR2820691215>3.0.CO;2-W","article-title":"Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients","volume":"69","author":"Pavlidis","year":"1992","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib63","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0006-2952(92)90258-K","article-title":"Effect of substrate organization on the activity and on the mechanism of gentamicin-induced inhibition of rat liver lysosomal\u00a0phospholipase A1","volume":"43","author":"Piret","year":"1992","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib64","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/14740338.5.4.567","article-title":"Drug-induced phospholipidosis: issues and future directions","volume":"5","author":"Reasor","year":"2006","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"10.1016\/j.survophthal.2016.11.008_bib65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.oftal.2012.09.017","article-title":"[Corneal chrysiasis. Gold salt deposits in the cornea in a patient with rheumatoid arthritis. An analysis with confocal microscopy]","volume":"88","author":"Santos-Bueso","year":"2013","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.11.008_bib66","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/toxsci\/kfh264","article-title":"A\u00a0toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in\u00a0vitro screening system","volume":"83","author":"Sawada","year":"2005","journal-title":"Toxicol Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2016.11.008_bib67","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0002-9394(14)72216-0","article-title":"Vortex keratopathy associated with atovaquone","volume":"120","author":"Shah","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.11.008_bib68","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2147\/OPTH.S49283","article-title":"Cloudy corneas as an initial presentation of multiple myeloma","volume":"8","author":"Sharma","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.11.008_bib69","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbalip.2012.08.013","article-title":"Drug induced phospholipidosis: an acquired lysosomal storage disorder","volume":"1831","author":"Shayman","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.survophthal.2016.11.008_bib70","series-title":"Cornea","first-page":"665","article-title":"Corneal manifestations of metabolic diseases","author":"Srinivasan","year":"2011"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib71","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1200\/JCO.1989.7.4.499","article-title":"Suramin: an anticancer drug with a unique mechanism of action","volume":"7","author":"Stein","year":"1989","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.11.008_bib72","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0002-9394(14)77969-3","article-title":"Keratopathy associated with the use of naproxen","volume":"99","author":"Szmyd","year":"1985","journal-title":"Am J Ophthalmol"},{"issue":"22","key":"10.1016\/j.survophthal.2016.11.008_bib73","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJM198605293142217","article-title":"Toxic keratopathy associated with suramin therapy","volume":"314","author":"Teich","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.survophthal.2016.11.008_bib74","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1442-9071.2007.01552.x","article-title":"Ocular toxicity of fluoroquinolones","volume":"35","author":"Thompson","year":"2007","journal-title":"Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.11.008_bib75","first-page":"479","article-title":"The risk of optic atrophy following suramin treatment of ocular onchocerciasis","volume":"57","author":"Thylefors","year":"1979","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.survophthal.2016.11.008_bib76","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00003226-199909000-00015","article-title":"An unreported side effect of topical clarithromycin when used successfully to treat Mycobacterium avium-intracellulare keratitis","volume":"18","author":"Tyagi","year":"1999","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.survophthal.2016.11.008_bib77","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1007\/s11095-015-1753-8","article-title":"In\u00a0vitro assessment of uptake and lysosomal sequestration of respiratory drugs in alveolar macrophage cell line NR8383","volume":"32","author":"Ufuk","year":"2015","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.survophthal.2016.11.008_bib78","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jama.298.11.1312","article-title":"Prescribing amiodarone: an evidence-based review of clinical indications","volume":"298","author":"Vassallo","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib79","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jcjo.2014.04.013","article-title":"Corneal deposit after topical ciprofloxacin as postoperative medication after cataract surgery","volume":"49","author":"Vijay Zawar","year":"2014","journal-title":"Can J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2016.11.008_bib80","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bjo.60.7.526","article-title":"Corneal changes in patients treated with clofazimine","volume":"60","author":"W\u00e5linder","year":"1976","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2016.11.008_bib81","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00417-011-1726-5","article-title":"Confocal laser-scanning microscopy allows differentiation between Fabry disease and amiodarone-induced keratopathy","volume":"249","author":"Wasielica-Poslednik","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.11.008_bib82","first-page":"854","article-title":"Adverse external ocular effects of topical ophthalmic therapy: an epidemiologic, laboratory, and clinical study","volume":"81","author":"Wilson","year":"1983","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"6","key":"10.1016\/j.survophthal.2016.11.008_bib83","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/ICO.0b013e3181922146","article-title":"Corneal verticillata after dual anti-epidermal growth factor receptor and anti-vascular endothelial growth factor receptor 2 therapy (vandetanib) for anaplastic astrocytoma","volume":"28","author":"Yeh","year":"2009","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.survophthal.2016.11.008_bib84","article-title":"Corneal manifestations of chronic systemic drug therapy","volume":"2","author":"Yip","year":"2011","journal-title":"J\u00a0Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.11.008_bib85","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4252\/wjsc.v6.i4.391","article-title":"Limbal stem cells: central concepts of corneal epithelial homeostasis","volume":"6","author":"Yoon","year":"2014","journal-title":"World J Stem Cells"},{"key":"10.1016\/j.survophthal.2016.11.008_bib86","series-title":"Kadcyla (ado-trastuzumab emtansine) for injection, for intravenous use","year":"2013"},{"key":"10.1016\/j.survophthal.2016.11.008_bib87","series-title":"Orphanet: Lisch epithelial corneal dystrophy. Orphanet [Internet]","author":"Klintworth","year":"2012"},{"issue":"23","key":"10.1016\/j.survophthal.2016.11.008_bib88","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1182\/blood.V126.23.182.182","article-title":"A\u00a0phase 1 study of denintuzumab mafodotin (SGN-CD19A) in relapsed\/refractory B-lineage non-Hodgkin lymphoma [abstract]","volume":"126","author":"Moskowitz","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.survophthal.2016.11.008_bib89","series-title":"The regulatory challenges of drug-induced phospholipidosis","author":"Sadrieh","year":"2010"},{"issue":"15 Suppl","key":"10.1016\/j.survophthal.2016.11.008_bib90","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1200\/jco.2015.33.15_suppl.2503","article-title":"Phase I studies of antiENPP3 antibody drug conjugates (ADCs) in advanced refractory renal cell carcinomas (RRCC) [abstract]","volume":"33","author":"Thompson","year":"2015","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625716301059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625716301059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:43:41Z","timestamp":1758541421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625716301059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0039625716301059"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2016.11.008","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced corneal epithelial changes","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2016.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}